Skip to main content

Allakos Inc.

ALLKDelisted May 15, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001564824

Allakos Inc. was delisted on May 15, 2025; its insiders filed their last Form 4 on May 19, 2025; 64 institutions reported holding it in 13F filings for Q1 2025, worth $14.1M in total; no superinvestor held it.

Q3 2023 vs. Q2 2023

How the institutions holding Allakos Inc. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023All holders in Q2 2023

13F holders of ALLK: Q2 2023 compared with Q3 2023
MeasureQ2 2023Q3 2023Change
Holders131118−13
Shares70.1M72.4M+2.30M (+3.3%)
Value$305.8M$164.4M−$141.4M (−46.2%)

New holders (15)

Institutions that held Allakos Inc. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to ALLK in Q3 2023
InstitutionSharesValue% of portfolio
Comprehensive Financial Management LLC220,163$499.8K0.02%
Woodline Partners LP213,422$484.5K0.01%
Industry Ventures, L.L.C.205,652$466.8K0.62%
XTX Topco Ltd155,841$353.8K0.06%
Standard Life Aberdeen plc131,347$298.2K0.00%
Wilshire Advisors LLC75,055$170.4K0.09%
HRT Financial LP73,048$165.0K0.00%
Utah Retirement Systems65,048$147.7K0.00%
Y-Intercept (Hong Kong) Ltd55,432$125.8K0.01%
SG Americas Securities, LLC41,876$95.0K0.00%
Two Sigma Securities, LLC10,653$24.2K0.00%
Occudo Quantitative Strategies LP10,583$24.0K0.00%
Douglas Lane & Associates, LLC10,051$22.8K0.00%
Headlands Technologies LLC732$1.66K0.00%
Red Tortoise LLC686$1.56K0.00%

Sold out (28)

Institutions that held Allakos Inc. at the end of Q2 2023 and filed for Q3 2023 without it.